STIFEL FINANCIAL CORP

Q3 2021 13F-HR Holdings

Location
St. Louis, MO
Holdings as of
9/30/2021
Date filed
11/15/2021
Form type
13F-HR
Num holdings
3,320
Total value ($000)
$68,199,290
Net value change ($000)
+1,381,184 (2.1%)
New positions
184
Sold out positions
174
Turnover %
0.6%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q2 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
USIG 175,216 52459.9%
Biohaven Pharmaceutical Holding Co Ltd. 166,445 66.7%
AGG 145,673 39.1%
MSFT 90,349 4.7%
COST 86,261 15.8%
QUAL 68,133 679.0%
PFE 62,054 14.0%
NFLX 48,461 39.8%
NOW 48,178 32.3%
ACN 47,483 10.5%
Top Reduces (Value $000, Stocks/ETFs)
VCIT -131,994 -71.2%
ITOT -105,202 -22.7%
BABA -78,924 -69.7%
VOO -70,455 -11.8%
SCHR -64,118 -43.3%
PYPL -47,159 -8.1%
CMCSA -35,121 -20.5%
MMM -31,653 -8.2%
V -31,483 -3.9%
UPS -29,246 -11.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type